FILTER

FILTERED INTERVIEW RESULTS

Christian Kopfli

CEO, CHROMOCELL
Chromocell is using its own Chrmovert technology to provide alternative pain blockers to opioids.

Renold Capocasale

CEO, FLOWMETRIC INC.
FlowMetric offers scientific analysis using Flow Cytometry to advance drug development.

Dirk van Peteghem

UPS VICE PRESIDENT, GLOBAL HEALTHCARE STRATEGY
UPS recently improved its offering to the pharmaceutical industry with the acquisition of Marken.

Scott Cubbler

COO LIFE SCIENCES & HEALTHCARE, GLOBAL, DHL SUPPLY CHAIN
DHL Supply Chain explains how the company keeps pace with changes such as recent demand for more biosimilars and personalized drugs.

Chris Molloy

SENIOR VICE PRESIDENT, OFFICE OF RESEARCH AND ECONOMIC DEVELOPMENT, RUTGERS UNIVERSITY
Rutgers University is a leading national research university that works alongside its corporate neighbors to foster developments in the health sector.

Debbie Hart

PRESIDENT AND CEO, BIONJ
BioNJ is involved in ensuring that New Jersey retains its leading position as a center of global life sciences by facilitating the industry’s development.

Gil Roth

THE PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION (PBOA)
The PBOA effectively promotes Contract Manufacturing organizations and protects their interests.

Dean J. Paranicas

PRESIDENT AND CEO, HEALTHCARE INSTITUTE OF NEW JERSEY (HINJ)
HealthCare Institute of New Jersey endeavors to ensure a favorable environment so that New Jersey remains at the center of global life science research.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Mexico Chemicals 2025 CW Release

Mexico's chemical industry faces challenges in securing a reliable feedstock supply and maintaining global competitiveness. A shift towards sustainable energy and local production could provide long-term growth opportunities, and some sectors are booming, including Mexico's dynamic chemical distribution market.

PARTNER EVENTS